Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.

Use of novel modulators targeting P-glycoprotein (P-gp, ABCB1 transporter) is among the most accepted strategies for overcoming multidrug resistance in cancer chemotherapy. In the current study, we pursued our structure-activity relationship studies of jatrophane derivatives by structural modification of compound 1, a natural jatrophane isolated from Euphorbia. sororia A. Nine compounds exhibited higher reversal activity in P-gp/ABCB1-mediated MCF-7/ADR cells than verapamil (VRP). The cytotoxicity and doxorubicin (DOX) intracellular accumulation effects of jatrophane derivatives were assessed in normal HEK293T cells and DOX-resistant MCF-7/ADR cells. The most potent compound 17 merits multiple activities, including (1) high efficiency (EC50 = 182.17 ± 32.67 nM) in reversing P-gp-mediated resistance to DOX, low cytotoxicity, and a high therapeutic index; and (2) increasing the accumulation of Rhodamine123 (Rho123) and DOX in a dose-dependent manner compared to verapamil in MCF-7/ADR cells. Our results indicated that the reversal activity of 17 was due to the stimulation of the P-gp ATPase activity instead of the direct inhibition of P-gp protein expression. A docking study demonstrated that 17 has a high binding affinity toward the DOX recognition site of P-gp. This resulted in 17 enhancing the sensitivity of DOX to MCF-7/ADR cells by stimulating P-gp ATPase activity, increasing intracellular DOX and Rho123 concentrations, inhibiting the phosphoinositide 3-kinase/serine-threonine kinase mediated by DOX and further reducing the expression of P-gp. This study provides a promising P-gp inhibitor for reversing multidrug resistance and provides a basis for further research.

Enantioselective construction of substituted pyridine and a seven-membered carbocyclic skeleton: biomimetic synthesis of (-)-rupestine D, (-)-guaipyridine, (-)-epiguaipyridine, and (-)-cananodine and their stereoisomers.

Guaipyridine alkaloids (-)-rupestine D, (-)-guaipyridine, (-)-epiguaipyridine, and (-)-cananodine together with two stereoisomers 8-epi-rupestine D and 5-epi-cananodine were synthesized enantioselectively from readily available citronellol. The key steps in this synthesis are (i) intermolecular opening of a trisubstituted epoxide for the formation of a chiral center at C-8; (ii) ring-closing metathesis for the construction of a seven-membered carbocyclic ring; and (iii) biomimetic cyclization of a 1,5-dicarbonyl compound for the construction of a pyridine-fused bicyclic skeleton.

Synthesis of pyranochalcone derivatives and their inhibitory effect on NF-κB activation.

In an effort to identify novel inhibitors of nuclear factor kappa B (NF-κB), twenty five pyranochalcone derivatives were synthesized and evaluated for their in vitro activities against TNF-α induced NF-κB inhibition in HEK293T cells. Among all of these derivatives, several displaying the same acrylate moiety on the B ring exhibited potent inhibition, with IC50 values ranging from 0.29 to 10.46 µM. A functional study of the most potent of these compounds, designated 6b, revealed that it significantly suppressed the transcriptional expression of inflammatory factor IL-1ß in lipopolysaccharide-induced RAW 264.7 macrophages, and also mildly inhibited CCL2, IL6 and TNF-α. In addition, compound 6b was found to inhibit IL-1ß released in LPS-induced BMDM cells. This study demonstrates that the inhibitory effect of 6b on LPS-stimulated inflammatory mediator production in the mouse macrophage cell line RAW 264.7 correlates with the suppression of the NF-κB and MAPK signaling pathways.

Diterpenoid alkaloids from Aconitum barbatum var. puberulum Ledeb.

Seven previously undescribed diterpenoid alkaloids, including five C20-diterpenoid alkaloids, barpuberudine, barpubesines A-D, and two C18-diterpenoid alkaloids, barpubenines A-B, along with 11 known diterpenoid alkaloids were isolated from the whole plant of Aconitum barbatum var. puberulum Ledeb. (Ranunculaceae). Barpuberudine is an unprecedented carbon skeleton of C20-diterpenoid alkaloid, while barpubenines A-B are the first example of rearranged types in C18-diterpenoid alkaloids. Their structures were elucidated based on a comprehensive spectroscopic data analysis. The probable pathway of biogenesis of barpuberudine and barpubenines A-B were discussed. Additionally, the antiarrhythmic, cytotoxic and antimicrobial activities of isolates were also evaluated.

Total synthesis of rupestine G and its epimers.

Rupestine G is a guaipyridine sesquiterpene alkaloid isolated from Artemisia rupestris L. The total synthesis of rupestine G and its epimers was accomplished employing a Suzuki reaction to build a terminal diene moiety. The diene was further elaborated into the desired guaipyridine structure by a ring-closing metathesis reaction. Over all, rupestine G and its three epimers were obtained as a mixture in a sequence of nine linear steps with 18.9% yield. Rupestine G and its optically pure isomers were isolated by chiral preparative HPLC and fully characterized by 1H ,13C NMR, HRMS, optical rotation value, and experimental and calculated electronic circular dichroism spectroscopy.

Total synthesis of (+)-iresin.

The first asymmetric total synthesis of (+)-iresin (4), an historically important ent-Drimane sesquiterpene lactone, was realized from aldehyde 3 via cyclic orthoester 6 in 5 steps. Notable transformations in this synthesis include a tandem trifluoroperacetic acid (TFPAA)-mediated Baeyer-Villiger oxidation-olefin epoxidation-epoxy ester cyclization, regioselective Burgess dehydration, and regioselective Fétizon oxidative lactonization.